Physician

Amrish Jain, M.D.

According to 2025 Medicare claims, Amrish Jain, M.D. (NPI: 1922202308) practices nephrology in the Detroit-Dearborn-Livonia, MI market, with the plurality of this provider's patient population coming from Wayne, MI. This provider's primary affiliated billing organization is UNIVERSITY PEDIATRICIANS (NPI: 1811920549; TIN: 383336414) and primary practice location at 48201-9998.

Jain's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 18 traditional Medicare patients, billed 279 HCPCS/CPT codes, and received $18,127 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 221 prescription claims across 14 beneficiaries totaling $12,274 in drug costs, led by Valganciclovir Hcl (Valganciclovir Hcl). DME data shows 294 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $13,491 and ending at $18,127. Concurrently, Part D prescription costs have declined steadily, from $116,730 to $12,274. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	25	160	$13,491
2016	20	180	$14,651
2017	20	231	$18,153
2018	25	263	$20,505
2019	19	168	$14,738
2020	21	126	$11,833
2021	21	157	$17,270
2022	15	114	$11,667
2023	16	176	$17,349
2024	18	279	$18,127

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	13	272	$116,730
2016	16	360	$80,720
2017	12	179	$82,601
2018	16	390	$123,654
2019	17	397	$89,083
2020	16	365	$72,388
2021	14	205	$44,324
2022	N/R	111	$10,737
2023	12	224	$23,484
2024	14	221	$12,274

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	226	$21,879
2016	N/R	222	$12,953
2017	45	264	$13,311
2018	49	523	$34,007
2019	34	388	$23,313
2020	N/R	265	$11,219
2021	N/R	245	$7,965
2022	N/R	206	$5,137
2023	N/R	315	$9,521
2024	N/R	294	$6,538

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	14	106	$113
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	14	114	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Valganciclovir Hcl	Valganciclovir Hcl	15	449	$9,581
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	30	900	$229
Prednisone	Prednisone	49	1,639	$214
Nifedipine Er	Nifedipine	12	540	$182
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	390	$169

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	72	$2,693
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	90	$1,600
J7517	Mycophenolate mofetil, oral, 250 mg	N	N/R	75	$1,505
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	57	$740

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Amrish Jain, M.D.?

Tedicare shows public-source Medicare data for Amrish Jain, M.D. (NPI 1922202308), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amrish Jain, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Amrish Jain, M.D.?

Amrish Jain, M.D. is linked to UNIVERSITY PEDIATRICIANS (billing NPI 1811920549) in the available physician profile data.

Does Amrish Jain, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.